Search Results - "Singh Bhadauria, Dharmendra"

Refine Results
  1. 1

    The Spectrum of Ocular Manifestations among Renal Transplant Recipients by Jain, Apoorva, Sen, Snigdha, Bhadauria, Dharmendra, Jain, Anu, Imchen, Merensoba

    Published in Indian journal of transplantation (01-01-2024)
    “…Purpose: The study aims to report various ocular manifestations among renal transplant recipients. Methods: The cross-sectional study was conducted on renal…”
    Get full text
    Journal Article
  2. 2
  3. 3

    High mortality and residual kidney damage with Coronavirus disease-19-associated acute kidney injury in northern India by Sharma, Harshita, Behera, Manas R., Bhadauria, Dharmendra Singh, Khushwaha, Ravi S., Yachha, Monika, Patel, Manas Ranjan, Kaul, Anupama, Prasad, Narayan

    Published in Clinical and experimental nephrology (01-11-2022)
    “…Background Acute kidney injury (AKI) is associated with morbidity and mortality in COVID-19 patients. The incidence of AKI and its outcomes vary in different…”
    Get full text
    Journal Article
  4. 4

    Urinary Mitochondrial DNA Induces an Inflammatory Response in Peripheral Blood Mononuclear Cells by Yadav, Brijesh, Prasad, Narayan, Kushwaha, Ravi Shanker, Singh, Ankita, Yadav, Deependra, Bhadauria, Dharmendra Singh, Kaul, Anupma

    Published in Indian journal of transplantation (01-04-2024)
    “…Background: Mitochondria are semiautonomous cell organelles having its own nucleic acid. Mitochondrial DNA (Mt-DNA) remain in hypomethylated (CpG) state and…”
    Get full text
    Journal Article
  5. 5

    Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation by Reddy, Suresh, Sharma, Raj Kumar, Mehrotra, Sonia, Prasad, Narayan, Gupta, Amit, Kaul, Anupma, Singh Bhadauria, Dharmendra

    Published in Clinical kidney journal (01-06-2018)
    “…ABSTRACT Background The objectives of this pilot study were to assess the efficacy and safety of an interferon-free sofosbuvir and ribavirin combination…”
    Get full text
    Journal Article
  6. 6

    Urinary Mitochondrial Deoxyribonucleic Acid: A Novel Biomarker of Coronavirus Disease 2019-associated Acute Kidney Injury in Renal Transplant Recipients by Yadav, Brijesh, Prasad, Narayan, Kushwaha, Ravi, Patel, Manas, Bhadauria, Dharmendra, Kaul, Anupma

    Published in Indian journal of transplantation (01-07-2023)
    “…Background: Acute kidney injury (AKI) is one of the common manifestations of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. An early…”
    Get full text
    Journal Article
  7. 7

    The Unusual Adverse Effects of Antituberculosis Therapy in Kidney Patients by Abdullah, Behera, Manas Ranjan, Kaul, Anupma, Agarwal, Vikas, Prasad, Pallavi, Prasad, Narayan, Bhadauria, Dharmendra Singh, Patel, Manas Ranjan, Sharma, Harshita

    Published in International journal of mycobacteriology (01-04-2024)
    “…Chronic kidney disease (CKD) patients are at a high risk of tuberculosis (TB), with a relative risk of developing active TB of 10%-25%. Similarly, glomerular…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Durability of ChAdOx1 nCoV-19 (Covishield ® ) Vaccine Induced Antibody Response in Health Care Workers by Verma, Alka, Goel, Amit, Katiyar, Harshita, Tiwari, Prachi, Mayank, Sana, Asari, Khetan, Dheeraj, Bhadauria, Dharmendra Singh, Raja, Ajay, Khokher, Neelam, Shalimar, Singh, Ratendra Kumar, Aggarwal, Amita

    Published in Vaccines (Basel) (30-12-2022)
    “…(i) Background: ChAdOx1 nCoV-19 (Covishield®) vaccine is widely used in India. We studied the Covishield® induced antibody response and its durability among…”
    Get full text
    Journal Article
  10. 10

    Serum levels of neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and cystatin-C in renal artery stenosis: A pilot study by Prasad, Raghunandan, Choudhary, Reeta, Singh, Anuradha, Agarwal, Surabhi, Kaushik, P, Singh, Kritika, Yadav, Rajanikant, Yadav, Amar, Bhadauria, Dharmendra, Lal, Hira

    Published in Indian journal of rheumatology (01-12-2020)
    “…Background: The present pilot study evaluated the potential of newer renal biomarkers (neutrophil gelatinase-associated lipocalin [NGAL], cystatin-C [Cys-c],…”
    Get full text
    Journal Article
  11. 11

    Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants by Mehrotra, Sonia, Sharma, Raj Kumar, Mayya, Mahabaleshwar, Gupta, Amit, Prasad, Narayan, Kaul, Anupma, Bhadauria, Dharmendra Singh

    Published in Experimental and clinical transplantation (01-08-2017)
    “…There are no reports of de novo donor-specific antibody monitoring by a low-cost solid-phase crossmatch assay using donor lysate after renal transplant. We…”
    Get full text
    Journal Article
  12. 12

    Typhoid-associated acute kidney injury masquerading as a relapse of takayasu arteritis by Manjunath, Revanasiddappa, Gupta, Amit, Bhadauria, Dharmendra Singh, Sharma, Raj Kumar, Kaul, Anupama, Prasad, Narayan

    “…Renal dysfunction is common in Takayasu arteritis. Uncommonly, renal failure in a case of Takayasu arteritis can be due to an unrelated disease, and if the…”
    Get full text
    Journal Article
  13. 13

    Hepatitis C virus infection and chronic renal disease: A review by Goel, Amit, Bhadauria, Dharmendra Singh, Aggarwal, Rakesh

    Published in Indian journal of gastroenterology (01-11-2018)
    “…Hepatitis C virus (HCV) is a parenterally-transmitted hepatotropic virus that often causes chronic infection, which can progress to cirrhosis and…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Seroprotection achieved with standard four-dose schedule of hepatitis B vaccine in people with chronic kidney disease: A real-life data by Singh, Surender, Mishra, Ajay Kumar, Yachha, Monika, Singh, Thakur Prashant, Katiyar, Harshita, Kaul, Anupma, Dhiman, Radha Krishna, Bhadauria, Dharmendra Singh, Goel, Amit

    Published in Indian journal of gastroenterology (19-09-2024)
    “…Hepatitis B virus (HBV) infection is common in people with chronic kidney diseases (CKD). The guidelines recommend four doses, 2.0 mL each, of HBV vaccine,…”
    Get full text
    Journal Article
  20. 20